Epithelial expression of interleukin-37b in inflammatory bowel disease

Clinical and Experimental Immunology

Volumn 172, Issue 3, 2013, Pages 410-416

  Imaeda, H ^a   Takahashi, K ^b   Fujimoto, T ^b   Kasumi, E ^a   Ban, H ^a   Bamba, S ^a   Sonoda, H ^a   Shimizu, T ^a   Fujiyama, Y ^a   Andoh, A ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Anti inflammatory cytokine; Innate immunity; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 37B; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADAPTIVE IMMUNITY; CACO-2 CELLS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CXCL10; COLITIS, ULCERATIVE; CROHN DISEASE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; INTESTINAL MUCOSA; MAP KINASE SIGNALING SYSTEM; MYOFIBROBLASTS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876732950     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12061     Document Type: Article

References (33)

1. Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol 2010; 45:9-16.
2. Andoh A, Imaeda H, Aomatsu T etal. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 2011; 46:479-486.
3. Andoh A, Kuzuoka H, Tsujikawa T etal. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol 2012; 47:1298-1307.
4. Franke A, McGovern DP, Barrett JC etal. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42:1118-1125.
5. Kobori A, Yagi Y, Imaeda H etal. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 2010; 45:999-1007.
6. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11:1014-1022.
7. Boraschi D, Lucchesi D, Hainzl S etal. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22:127-147.
8. Dinarello C, Arend W, Sims J etal. IL-1 family nomenclature. Nat Immunol 2010; 11:973.
9. Bufler P, Azam T, Gamboni-Robertson F etal. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002; 99:13723-13728.
10. Kumar S, Hanning CR, Brigham-Burke MR etal. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002; 18:61-71.
11. Sharma S, Kulk N, Nold MF etal. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008; 180:5477-5482.
12. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381:503-510.
13. McNamee EN, Masterson JC, Jedlicka P etal. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011; 108:16711-16716.
14. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298:82-86.
15. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979; 77:843-846.
16. Fujino S, Andoh A, Bamba S etal. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52:65-70.
17. Dharmsathaphorn K, McRoberts JA, Mandel KG, Tisdale LD, Masui H. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 1984; 246:G204-208.
18. Mahida YR, Beltinger J, Makh S etal. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol 1997; 273:G1341-1348.
19. Andoh A, Fujino S, Bamba S etal. IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J Immunol 2002; 169:1683-1687.
20. Kumar S, McDonnell PC, Lehr R etal. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000; 275:10308-10314.
21. Shimada M, Andoh A, Hata K etal. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol 2002; 168:861-868.
22. Inatomi O, Andoh A, Kitamura K, Yasui H, Zhang Z, Fujiyama Y. Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts. J Gastroenterol 2005; 40:483-489.
23. Obara H, Takayanagi A, Hirahashi J etal. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20:2198-2204.
24. Yasumoto H, Kim S, Zhan Y etal. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther 2001; 8:1682-1689.
25. Favata MF, Horiuchi KY, Manos EJ etal. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273:18623-18632.
26. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-27494.
27. Cuenda A, Rouse J, Doza YN etal. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364:229-233.
28. Fang J, Ding M, Yang L, Liu LZ, Jiang BH. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 2007; 19:2487-2497.
29. Liu M, Guo S, Hibbert JM etal. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011; 22:121-130.
30. Hata K, Andoh A, Shimada M etal. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2002; 282:G1035-1044.
31. Shioya M, Nishida A, Yagi Y etal. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007; 149:480-486.
32. Koyasu S, Moro K. Type 2 innate immune responses and the natural helper cell. Immunology 2011; 132:475-481.
33. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-490.